 |
|
|
| |
6-Month Outcomes of Every 2 Months
Long-Acting Cabotegravir and Rilpivirine in a Real-World Setting - Effectiveness, Adherence to Injections, and Patient- Reported Outcomes of People Living With HIV in the German CARLOS Cohort
|
| |
| |
Glasgow 2022 Oct 23-26
Jan Borch1, Jenny Scherzer2, Celia Jonsson-Oldenbüttel3, Gordon Weinberg4,
Christoph Wyen5, Elena Rodriguez6, Stefan Scholten7, Samia Dakhia8, Kathrin Dymek2,
Bernd Westermayer9, Katharina Bernhardt2
1Praxis Goldstein, Berlin, Germany; 2ViiV Healthcare, Munich, Germany; 3MVZ München am Goetheplatz, Munich, Germany;
4Infektiologisches Zentrum Steglitz, Berlin, Germany; 5Praxis am Ebertplatz Cologne, Germany; 6Praxisgemeinschaft ViRo Schillerkiez, Berlin, Germany;
7Praxis Hohenstaufenring, Cologne, Germany; 8ViiV Healthcare, Brentford, London, United Kingdom; 9GlaxoSmithKline, Munich, Germany
|
| |
|
|
|
|
|
